NCT01864096 2024-01-24
MAST
University Health Network, Toronto
Phase 3 Unknown
Clinical Trials
70 trialsNCT06011304 2023-10-23
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
HTA Co., Ltd.
Phase 3 Unknown
NCT01949337 2023-09-28
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Unknown
NCT02948543 2023-06-18
BCG+MM
University of Sydney
Phase 3 Unknown
NCT05816668 2023-04-18
Transamin
Instituto do Cancer do Estado de São Paulo
Phase 3 Unknown
NCT01675219 2023-04-13
Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Turku University Hospital
Phase 3 Unknown
NCT04139772 2023-03-24
Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
National Cancer Institute, Naples
Phase 3 Unknown
NCT05244577 2023-02-06
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT04026230 2022-10-21
ESTO2
Tampere University Hospital
Phase 3 Unknown
NCT05392634 2022-05-31
MACS
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Unknown
NCT04764487 2022-05-03
AxiPRO
Weprom
Phase 3 Unknown
NCT04490993 2022-02-22
ACCRUE
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 3 Unknown
NCT04736394 2022-02-22
ASCERTAIN
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 3 Unknown
NCT03119857 2021-08-18
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14
Göteborg University
Phase 3 Unknown
NCT04939194 2021-06-25
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
Mansoura University
Phase 3 Unknown
NCT04859751 2021-04-26
Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT03664869 2021-04-01
FB10
Turku University Hospital
Phase 3 Unknown
NCT03520478 2021-03-02
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT03095040 2021-02-08
CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma
AnewPharma
Phase 3 Unknown
NCT04734184 2021-02-02
Python
Curium PET France
Phase 3 Unknown
NCT00667888 2021-01-25
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
M.D. Anderson Cancer Center
Phase 3 Unknown
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT03458559 2020-11-17
RaRe
Amsterdam UMC, location VUmc
Phase 3 Unknown
NCT04568304 2020-09-29
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 3 Unknown
NCT01993979 2020-05-04
POUT
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT02928692 2020-01-28
MAPOCD
RenJi Hospital
Phase 3 Unknown
NCT03623425 2018-08-09
TEPGALCHOL
Central Hospital, Nancy, France
Phase 3 Unknown
NCT03580239 2018-07-09
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
Tianjin Medical University Second Hospital
Phase 3 Unknown
NCT03406169 2018-01-23
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Brooke Army Medical Center
Phase 3 Unknown
NCT03296306 2017-09-28
FOCUS
Asan Medical Center
Phase 3 Unknown
NCT02044354 2017-08-08
CABA-DOC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown
NCT03193788 2017-06-21
PREMIER
Asan Medical Center
Phase 3 Unknown
NCT01099423 2017-02-08
SURTIME
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Unknown
NCT02934685 2016-11-18
IG-VMAT for Localized Prostate Cancer
Beijing Hospital
Phase 3 Unknown
NCT02951078 2016-11-01
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3 Unknown
NCT01354171 2016-10-14
ASIST
Canadian Urology Research Consortium
Phase 3 Unknown
NCT02367404 2016-09-13
Prospective RCT on Post Prostatectomy Urine Leak
Institut Mutualiste Montsouris
Phase 3 Unknown
NCT00003734 2016-07-21
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01978873 2016-05-04
SensiCab
Örebro University, Sweden
Phase 3 Unknown
NCT02668718 2016-02-02
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer
Helsinki University Central Hospital
Phase 3 Unknown
NCT01581723 2015-02-04
Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor
Chinese University of Hong Kong
Phase 3 Unknown
NCT00003804 2014-06-24
Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00047138 2014-06-24
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00175396 2014-03-17
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
University of British Columbia
Phase 3 Unknown
NCT02074189 2014-02-28
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer
Southwest Hospital, China
Phase 3 Unknown
NCT00553124 2014-01-10
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00553345 2014-01-10
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003725 2013-11-06
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00274950 2013-09-17
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00363285 2013-08-26
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown